These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 10908308

  • 1. CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides.
    Bläker M, Ren Y, Seshadri L, McBride EW, Beinborn M, Kopin AS.
    Mol Pharmacol; 2000 Aug; 58(2):399-406. PubMed ID: 10908308
    [Abstract] [Full Text] [Related]

  • 2. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.
    Beinborn M, Chen C, DeMeo L, McBride EW, Kopin AS.
    Yale J Biol Med; 1998 Aug; 71(3-4):337-46. PubMed ID: 10461364
    [Abstract] [Full Text] [Related]

  • 3. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Bläker M, Ren Y, Gordon MC, Hsu JE, Beinborn M, Kopin AS.
    Mol Pharmacol; 1998 Nov; 54(5):857-63. PubMed ID: 9804620
    [Abstract] [Full Text] [Related]

  • 4. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity.
    Ren Y, Bläker M, Seshadri L, McBride EW, Beinborn M, Kopin AS.
    J Mol Neurosci; 2003 Apr; 20(2):115-24. PubMed ID: 12794305
    [Abstract] [Full Text] [Related]

  • 5. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands.
    Kopin AS, McBride EW, Quinn SM, Kolakowski LF, Beinborn M.
    J Biol Chem; 1995 Mar 10; 270(10):5019-23. PubMed ID: 7890609
    [Abstract] [Full Text] [Related]

  • 6. Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy.
    Kopin AS, McBride EW, Gordon MC, Quinn SM, Beinborn M.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):11043-8. PubMed ID: 9380756
    [Abstract] [Full Text] [Related]

  • 7. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin.
    Silvente-Poirot S, Wank SA.
    J Biol Chem; 1996 Jun 21; 271(25):14698-706. PubMed ID: 8663021
    [Abstract] [Full Text] [Related]

  • 8. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A, Lutz J, Escrieut C, Fourmy D, van Neuren AS, Müller G, Schafferhans A, Klebe G, Moroder L.
    Biopolymers; 1996 Jun 21; 56(2):55-76. PubMed ID: 11592053
    [Abstract] [Full Text] [Related]

  • 9. The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding.
    Mantamadiotis T, Baldwin GS.
    Biochem Biophys Res Commun; 1994 Jun 30; 201(3):1382-9. PubMed ID: 8024583
    [Abstract] [Full Text] [Related]

  • 10. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
    Schmitz F, Pratt DS, Wu MJ, Kolakowski LF, Beinborn M, Kopin AS.
    Mol Pharmacol; 1996 Aug 30; 50(2):436-41. PubMed ID: 8700154
    [Abstract] [Full Text] [Related]

  • 11. CCK-B/gastrin receptors in human colorectal cancer.
    Schmitz F, Otte JM, Stechele HU, Reimann B, Banasiewicz T, Fölsch UR, Schmidt WE, Herzig KH.
    Eur J Clin Invest; 2001 Sep 30; 31(9):812-20. PubMed ID: 11589724
    [Abstract] [Full Text] [Related]

  • 12. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Fréhel D, Gully D, Vaysse N, Fourmy D.
    J Biol Chem; 1997 Jan 31; 272(5):2920-6. PubMed ID: 9006937
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of gastrin-stimulated cell proliferation by the CCK-B/gastrin receptor ligand CI-988.
    Dethloff LA, Barr BM, Bestervelt LL.
    Food Chem Toxicol; 1999 Jan 31; 37(2-3):105-10. PubMed ID: 10227733
    [Abstract] [Full Text] [Related]

  • 14. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov 31; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

  • 15. Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells.
    Schmitz F, Schrader H, Otte J, Schmitz H, Stüber E, Herzig K, Schmidt WE.
    Regul Pept; 2001 Sep 15; 101(1-3):25-33. PubMed ID: 11495676
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
    Dezube M, Sugg EE, Birkemo LS, Croom DK, Dougherty RW, Ervin GN, Grizzle MK, James MK, Johnson MF, Mosher JT.
    J Med Chem; 1995 Aug 18; 38(17):3384-90. PubMed ID: 7650691
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
    de Tullio P, Delarge J, Pirotte B.
    Curr Med Chem; 1999 Jun 18; 6(6):433-55. PubMed ID: 10213792
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.